OGN Organon & Co.

-

Organon Missed Consensus Estimates

Friday, July 31, 2026 · 12:00 AM ET

Organon (OGN) reported earnings of $0.80 per share on revenue of $1.56 billion for the second quarter ended June 2026. The consensus earnings estimate was $0.85 per share. The company missed consensus estimates by 5.88% while revenue fell 2.26% compared to the same quarter a year ago.

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.

Earnings Whisper Grade
Power Rating
Reported Earnings
$0.80
Earnings Whisper®
Consensus Estimate
$0.85
Earnings Surprise
Earnings Growth-14.9 %
Reported Revenue
$1.56B
Revenue Estimate
Revenue Surprise
Revenue Growth-2.3 %